Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
7.67
-1.20 (-13.53%)
At close: Nov 16, 2026, 4:00 PM EST
8.00
+0.33 (4.30%)
Pre-market: Nov 17, 2026, 5:59 AM EST
Helus Pharma Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Helus Pharma stock has a consensus rating of "Strong Buy" and an average price target of $45.54. The average 1-year stock price forecast is 493.74% higher than the current stock price, while the lowest is $14.83 (+93.35%) and the highest is $79.06 (+930.77%).
Price Target: $45.54 (+493.74%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Helus Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 10 | 10 | 10 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lucid Capital | Lucid Capital | Buy Maintains $52 → $79 | Buy | Maintains | $52 → $79 | +929.99% | Nov 16, 2026 |
| Jefferies | Jefferies | Buy Maintains $22 | Buy | Maintains | $22 | +186.83% | Nov 16, 2026 |
| Barclays | Barclays | Buy Maintains $35 | Buy | Maintains | $35 | +356.32% | Nov 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 → $70 | Buy | Reiterates | $60 → $70 | +812.65% | Nov 16, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $45 | Buy | Reiterates | $45 | +486.70% | Oct 23, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
16.56M
EPS This Year
-3.80
from -4.14
EPS Next Year
-2.04
from -3.80
EPS and Forward PE are based on non-GAAP adjusted numbers.